FDA Oks Pfizer for Children 5-11 Years Old
PFIZER – The COVID-19 vaccine got the approval of the Food and Drugs Administration (FDA) for children aged 5-11.
Amid the threats of a new variant of COVID-19 now, the Omicron variant, many countries are boosting their vaccination programs. One of these is the Philippines which recently held mass vaccinations.
The first mass vaccination was held from November 29 to December 1. In some areas, it was extended until December 3, 2021. The said first mass vaccination drive vaccinated 10.2 million Filipinos. It was followed by another mass vaccination drive that was held last December 15 to 17. It targeted the vaccination of seven (7) million Filipinos.
However, due to Typhoon Odette, the mass vaccination was postponed in some areas. Vaccines keep on arriving in the country.
The vaccination program in the Philippines observed a priority ladder. The top priorities are the healthcare workers, the senior citizens, and the individuals with co-morbidities. The vaccination is now open to the general adult population and specified brackets of children ages.
Recently, based on a report on ABS-CBN News, the Food and Drug Administration (FDA) approved Pfizer for children aged 5-11 years old. The agency said that the benefits of the vaccine “outweigh the known and potential risks” and the US FDA has provided sufficient data for approval.
Currently, the giving of booster shots is also ongoing in the Philippines. It got the go signal for the fully-vaccinated healthcare workers, senior citizens, and people with co-morbidities. The government is boosting the vaccination program following the emergency of the Omicron variant which was reported to be a “heavily mutated” variant of the virus.
The Omicron variant was first recorded in South Africa. Currently, several countries across the globe have logged cases of the said virus including the Philippines. The Department of Health (DOH) confirmed three (3) cases of Omicron variant in travelers from abroad.
Thank you for visiting Philnews.ph. You may express your thoughts and reactions below through the comment section. You may also follow us on Facebook, on Twitter, and subscribe to our YouTube channel Philnews Ph.